Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR vs Risperidone for Depressive Symptoms in Schizophrenia
NCT00640562Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2008
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in schizophrenia, schizoaffective disorder, sponsored by AstraZeneca. Started Feb 2008; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00640562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640562.